Monday, June 15, 2026

Oil Prices Surge Over 2%: What Trump’s Failed Military Request Means for Asia

Oil prices rebound as allies reject Trump's military request for the Strait of Hormuz, with WTI rising 2.31% to $95.65 per barrel.

Golf, Politics, and Power: Lobby Teases a Thrilling Look at Lobbying in Korea

The film *Lobby* explores the high-stakes world of lobbying through Chang Wook, a startup CEO, aiming for a $3 billion contract.

Samsung Electronics at the 2026 Winter Olympics: Inside the IOC Gala Where JD Vance and Global CEOs Converged

Lee Jae Yong of Samsung Electronics engages in sports diplomacy at the 2026 Winter Olympics, enhancing global ties and brand visibility.

Tag: Yuflyma

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

Top News

- Our Sponsors Ad -

Follow us